Skip to main content

Advertisement

Table 2 Clinical characteristics of the TCGA PRAD cohort and the preselected subcohort

From: Random forest-based modelling to detect biomarkers for prostate cancer progression

  TCGA PRAD TCGA PRAD subcohort
Full cohort Good prognosisa Poor prognosisa
n 477 27 57
Age (mean ± sd) 61.06 ± 6.9 57.23 ± 6.7 62.46 ± 6
Stage (path. T)
 n.a. 6 0 0
 pT2a 13 1 0
 pT2b 6 3 0
 pT2c 161 23 0
 pT3a 153 0 24
 pT3b 129 0 31
 pT4 9 0 2
Gleason score
 6 43 6 0
 7 243 17 12
 8 61 2 8
 9 127 2 36
 10 3 0 1
  1. n.a. not available
  2. aGood prognosis defined as lack of BCR for at least 5 years and stage < pT3. Poor prognosis defined as BCR within 3 years and stage ≥ pT3